RCKT Investors Have the Opportunity to Lead the Rocket Pharmaceuticals Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501's safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial's protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket's securities at artificially inflated prices.
On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made 'several months' earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred.
Following this news, the price of Rocket's common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket's stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Rocket's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Rocket Pharmaceuticals class action, go to www.faruqilaw.com/RCKT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Align Technology (ALGN) Dives 37% on Lower Price Target, Pessimistic Rating
We recently published . Align Technology, Inc. (NASDAQ:ALGN) is one of the worst-performing stocks on Thursday. Align Technology fell to a new low on Thursday as investors sold off positions after missing earnings expectations and earning a lower price target and pessimistic rating from an investment firm. In intra-day trading, Align Technology, Inc. (NASDAQ:ALGN) dropped to its lowest price of $127.7 before slight buying pushed the company's share price higher to end the day just down by 36.63 percent at $129.01 apiece. This followed mixed earnings performance during the quarter that saw the company record a non-GAAP net income of $181.1 million, flat from last year. GAAP net income, on the other hand, amounted to $124.6 million, or 29 percent higher than the $93.2 million in the same period last year. Net revenues, on the other hand, dipped by 1.6 percent to $1.012 billion from $1.028 billion year-on-year. In other developments, Mizuho reduced its price target for Align Technology, Inc. (NASDAQ:ALGN) to $210 from $245 previously, but maintained an 'outperform' rating for the stock. Mizuho's revision followed reports about June trends, which fell short of expectations, despite the company's hosting of an 'upbeat analyst meeting' in May this year. Pixabay/Public domain Additionally, the revision reflected the weaker-than-expected patient conversion rates despite iTero scans and Invisalign doctor case submissions appearing to remain on track. While we acknowledge the potential of ALGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Why Applied Digital Stock Is Sinking Today
Key Points Applied Digital stock rocketed higher yesterday, but macroeconomic concerns are pushing its share price lower today. The July jobs report showed fewer-than-expected additions, and jobs estimates for May and June saw big downward revisions. The stock market as a whole is also under pressure due to new tariffs introduced by President Trump yesterday. 10 stocks we like better than Applied Digital › Applied Digital (NASDAQ: APLD) stock is losing ground Friday after posting huge gains in yesterday's session. The company's share price was down 3.7% as of 2:10 p.m. ET. At the same point in the day, the S&P 500 (SNPINDEX: ^GSPC) was down 1.8%, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) was down 2.5%. Applied Digital stock had been down as much as 13.2% shortly after the market opened, but its valuation has regained significant ground in subsequent trading. The strength of the company's recent earnings report has likely helped reduce its valuation slide on the day, but the stock is still seeing a significant pullback in response to the latest U.S. jobs report and other macroeconomic concerns. Applied Digital stock is slipping in response to jobs numbers and tariffs The Bureau of Labor Statistics (BLS) published its July jobs report this morning and amended previously reported figures for June and May. The BLS report showed that only 73,000 nonfarm jobs were added to the U.S. economy last month -- well below the 100,000 job additions called for by the average economist estimate. Making matters worse, June's estimated jobs growth was revised from 147,000 to 14,000, and May's jobs growth was lowered from 144,000 to 19,000. Adding another bearish pressure to the broader market, President Trump signed an executive order yesterday evening that introduced new tariffs on a wide range of countries. The tariffs are set to go into effect on Aug. 7, which means there is very little time for countries to negotiate trade deals that could mitigate the new import taxes. What's next for Applied Digital? Macroeconomic developments will continue to play a key role in shaping performance for Applied Digital and the broader market. Stocks have been on an impressive rally over the last few months, and major indexes have recently set new highs, but some recent economic data has raised concerns about how much momentum is left in the recent bull run. Concerns about the overall health of the economy and the possibility that the Federal Reserve may have waited too long to lower interest rates could continue to weigh on valuations. On the other hand, Applied Digital is coming off of some big wins. The company's recent announcement that artificial intelligence (AI) specialist CoreWeave has exercised an option for an additional 150 megawatts of data-center processing is a clear bullish development and points to a promising long-term outlook. Should you buy stock in Applied Digital right now? Before you buy stock in Applied Digital, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Applied Digital wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Applied Digital Stock Is Sinking Today was originally published by The Motley Fool Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
Yahoo
an hour ago
- Yahoo
Confluent (CFLT) Hits New Low on Weak Revenue Outlook
We recently published . Confluent, Inc. (NASDAQ:CFLT) is one of the worst-performing stocks on Thursday. Confluent fell for a fourth consecutive day on Thursday, to touch a new low of $17.51 apiece, as investor sentiment was dampened by its lower-than-expected revenue for the second quarter of the year. During the period, Confluent, Inc. (NASDAQ:CFLT) grew its total revenues by 20 percent to $282 million from $235 million in the same period last year, as subscription revenues increased by 21 percent to $270.8 million from $224.7 million. However, total revenues missed analysts' consensus forecast by 2.69 percent. In the same period, net loss also narrowed by 8.8 percent to $81.95 million from $89.9 million year-on-year. In the first half, net loss shrank by 18.6 percent to $149.5 million from $183 million year-on-year, as total revenues grew 22 percent to $553 million from $452 million. Looking ahead, Confluent, Inc. (NASDAQ:CFLT) expects subscription revenues to end between $281-$282 million, and to a range of $1.105 billion to $1.11 billion in the full-year period. Copyright: buchachon / 123RF Stock Photo Earnings per share were also pegged at $0.09-$0.10 in the third quarter and at around $0.36 in the full year. While we acknowledge the potential of CFLT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
